(S)-1-Amino-3-(3,4-dihydroisoquinolin-2(1H)-yl)propan-2-ol hydrochloride, 95+%, 25g

4-Bromo-2-methylbenzyl Alcohol>98.0%(GC)5g

Fmoc-D-Tic-OH, 95.0%, 10g

5-Nitrobenzo[c][1,2,5]thiadiazole, 95.0%, 500mg

Phentolamine Mesylate>98.0%(HPLC)(T)100mg

Tris(2,2,2-trifluoroethyl) Phosphite>98.0%(GC)25g

Bicyclo[3.2.1]octane-3-carboxylic acid, 98%, 100mg

5,6-Dibromoacenaphthylene-1,2-dione, 98%, 1g

N-(piperidin-4-yl)cyclopropanesulfonamide hydrochloride, 95.0%, 500mg

1-(9,10-Dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-yl)-2,2,2-trifluoroethanone, 98%, 100g

GC capillary column ROTI®Cap-1, 15 m, 0.32 mm, 1.00 µm, 1 Piece(s)

3-Fluoro-5-nitropyridine, 95.0%, 250mg

2-(2-Methoxyphenyl)-5-oxotetrahydrofuran-3-carboxylic acid, 97.0%, 1g